Related references
Note: Only part of the references are listed.Outpatient management of incidental pulmonary embolism in cancer patient
Andres J. Munoz Martin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States
Ang Li et al.
CANCER (2020)
Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer
Julia Rose Salinaro et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation A Systematic Review and Meta-Analysis
Aya F. Ozaki et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)
Anna Fagotti et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Direct oral anticoagulants versus aspirin for venous thromboembolism prophylaxis after orthopedic surgery
Tianrui Yang et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice
Stephan V. Hendriks et al.
THROMBOSIS RESEARCH (2019)
Blood Transfusion Cost, Quality, and Other Considerations for the Surgical Management of the Critically Ill
Michelle Keasling Jankite
CRITICAL CARE NURSING QUARTERLY (2019)
The end of life costs for Medicare patients with advanced ovarian cancer
Renata R. Urban et al.
GYNECOLOGIC ONCOLOGY (2018)
Neoadjuvant chemotherapy is associated with more anemia and perioperative blood transfusions than primary debulking surgery in women with advanced stage ovarian cancer
Andrea O'Shea et al.
GYNECOLOGIC ONCOLOGY (2018)
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty
D. R. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
David Cameron et al.
GLOBAL HEALTH ACTION (2018)
Comparison of survival between upfront primary debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomized trial: JCOG0602.
Takashi Onda et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery
Kevin W. McCool et al.
BMC CANCER (2018)
Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
Patricia S. Greco et al.
OBSTETRICS AND GYNECOLOGY (2017)
Clinical impact of major bleeding in patients with venous thrombo-embolism treated with factor Xa inhibitors or vitamin K antagonists
Suzanne M. Bleker et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
Ryan T. Borne et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Impact of body mass index on ovarian cancer survival varies by stage
Elisa V. Bandera et al.
BRITISH JOURNAL OF CANCER (2017)
Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States
Alexander Melamed et al.
GYNECOLOGIC ONCOLOGY (2016)
The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer
Renata R. Urban et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
A preoperative personalized risk assessment calculator for elderly ovarian cancer patients undergoing primary cytoreductive surgery
Emma L. Barber et al.
GYNECOLOGIC ONCOLOGY (2015)
A cost-utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer
David E. Cohn et al.
GYNECOLOGIC ONCOLOGY (2015)
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean Kehoe et al.
LANCET (2015)
Outpatient Management of Pulmonary Embolism in Cancer: Data on a Prospective Cohort of 138 Consecutive Patients
Carme Font et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival
Feras Abu Saadeh et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
Estimating Quality of Life in Acute Venous Thrombosis
Kerstin Hogg et al.
JAMA INTERNAL MEDICINE (2013)
Paraneoplastic Thrombocytosis in Ovarian Cancer
Rebecca L. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Epidemiology and pathophysiology of cancer-associated thrombosis
S. Noble et al.
BRITISH JOURNAL OF CANCER (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: An administrative claims analysis from 30 managed care organizations
Alex C. Spyropoulos et al.
JOURNAL OF MANAGED CARE PHARMACY (2007)
Venous thromboembolism in ovarian cancer
Anne O. Rodriguez et al.
GYNECOLOGIC ONCOLOGY (2007)
Unsuspected pulmonary emboli in cancer patients: Clinical correlates and relevance
Casey L. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Ovarian cancer and venous thromboembolic risk
S Tateo et al.
GYNECOLOGIC ONCOLOGY (2005)
Share Paper
